Literature DB >> 23406874

Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes.

Adrian Cortes1, Judith Field, Evgeny A Glazov, Johanna Hadler, Jim Stankovich, Matthew A Brown.   

Abstract

Multiple sclerosis (MS) is a common chronic inflammatory disease of the central nervous system. Susceptibility to the disease is affected by both environmental and genetic factors. Genetic factors include haplotypes in the histocompatibility complex (MHC) and over 50 non-MHC loci reported by genome-wide association studies. Amongst these, we previously reported polymorphisms in chromosome 12q13-14 with a protective effect in individuals of European descent. This locus spans 288 kb and contains 17 genes, including several candidate genes which have potentially significant pathogenic and therapeutic implications. In this study, we aimed to fine-map this locus. We have implemented a two-phase study: a variant discovery phase where we have used next-generation sequencing and two target-enrichment strategies [long-range polymerase chain reaction (PCR) and Nimblegen's solution phase hybridization capture] in pools of 25 samples; and a genotyping phase where we genotyped 712 variants in 3577 healthy controls and 3269 MS patients. This study confirmed the association (rs2069502, P = 9.9 × 10(-11), OR = 0.787) and narrowed down the locus of association to an 86.5 kb region. Although the study was unable to pinpoint the key-associated variant, we have identified a 42 (genotyped and imputed) single-nucleotide polymorphism haplotype block likely to harbour the causal variant. No evidence of association at previously reported low-frequency variants in CYP27B1 was observed. As part of the study we compared variant discovery performance using two target-enrichment strategies. We concluded that our pools enriched with Nimblegen's solution phase hybridization capture had better sensitivity to detect true variants than the pools enriched with long-range PCR, whilst specificity was better in the long-range PCR-enriched pools compared with solution phase hybridization capture enriched pools; this result has important implications for the design of future fine-mapping studies.

Entities:  

Mesh:

Year:  2013        PMID: 23406874     DOI: 10.1093/hmg/ddt062

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  8 in total

Review 1.  The next-generation sequencing revolution and its impact on genomics.

Authors:  Daniel C Koboldt; Karyn Meltz Steinberg; David E Larson; Richard K Wilson; Elaine R Mardis
Journal:  Cell       Date:  2013-09-26       Impact factor: 41.582

2.  Analysis of CYP27B1 in multiple sclerosis.

Authors:  Jay P Ross; Cecily Q Bernales; Joshua D Lee; A Dessa Sadovnick; Anthony L Traboulsee; Carles Vilariño-Güell
Journal:  J Neuroimmunol       Date:  2013-11-23       Impact factor: 3.478

3.  The Association Between Genetic Polymorphism rs703842 in CYP27B1 and Multiple Sclerosis: A Meta-Analysis.

Authors:  Tao Jiang; Lizhuo Li; Ying Wang; Chuntao Zhao; Jundong Yang; Dexuan Ma; Yanlei Guan; Dan Zhao; Yijun Bao; Yunjie Wang; Jingyun Yang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

4.  Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole-exome next generation sequencing.

Authors:  Vanesa Pytel; Jordi A Matías-Guiu; Laura Torre-Fuentes; Paloma Montero-Escribano; Paolo Maietta; Javier Botet; Sara Álvarez; Ulises Gómez-Pinedo; Jorge Matías-Guiu
Journal:  Brain Behav       Date:  2019-03-21       Impact factor: 2.708

Review 5.  A catalog of GWAS fine-mapping efforts in autoimmune disease.

Authors:  Minal Caliskan; Christopher D Brown; Joseph C Maranville
Journal:  Am J Hum Genet       Date:  2021-04-01       Impact factor: 11.025

6.  What is the Real Fate of Vitamin D in Multiple Sclerosis?

Authors:  Vahid Shaygannejad; Zahra Tolou-Ghamari
Journal:  Int J Prev Med       Date:  2013-05

Review 7.  Cracking the Code of Human Diseases Using Next-Generation Sequencing: Applications, Challenges, and Perspectives.

Authors:  Vincenza Precone; Valentina Del Monaco; Maria Valeria Esposito; Fatima Domenica Elisa De Palma; Anna Ruocco; Francesco Salvatore; Valeria D'Argenio
Journal:  Biomed Res Int       Date:  2015-11-19       Impact factor: 3.411

8.  Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.

Authors:  Michele D Binder; Andrew D Fox; Daniel Merlo; Laura J Johnson; Lauren Giuffrida; Sarah E Calvert; Rainer Akkermann; Gerry Z M Ma; Ashwyn A Perera; Melissa M Gresle; Louise Laverick; Grace Foo; Marzena J Fabis-Pedrini; Timothy Spelman; Margaret A Jordan; Alan G Baxter; Simon Foote; Helmut Butzkueven; Trevor J Kilpatrick; Judith Field
Journal:  PLoS Genet       Date:  2016-03-18       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.